Bridge Therapeutics

Pharmaceutical Manufacturing • Birmingham, Alabama, United States • 1-10 Employees

Company overview

Headquarters	1160 Huffman Rd., Birmingham, Alabama 35215, US
Phone number	+18772236949
Website	bridgetherapeutics.com
NAICS	3254
SIC	283
Keywords	Drug Development
Founded	2016
Employees	1-10
Socials

Key Contacts at Bridge Therapeutics

Alton Kelley

Director Of Business Development

David H. Bergstrom

Chief Executive Officer

About Bridge Therapeutics

Bridge Therapeutics®, based in Birmingham, Ala., is an innovative development-stage specialty pharmaceutical company pursuing U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals of a patented (U.S. Patent #8410092) drug combination, BT-205, for the treatment of chronic pain in opioid-experienced patients. The investigational drug BT-205 is a unique combination of two synergistic chronic pain drugs—the partial-agonist opioid buprenorphine and the NSAID meloxicam—delivered in a state-of-the-art sublingual formulation. The dosing and delivery method will be a commercial advantage over the current alternatives. Bridge Therapeutics' goal is to make the BT-205 compound and other investigational new drug candidates available to millions of patients in which addictive and potentially dangerous full-agonist opioids such as oxycodone and morphine are ineffective and/or unsatisfactory. For more information, visit www.bridgetherapeutics.com.

Bridge Therapeutics revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$2,000,000
Total funding	$3,000,000

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

Bridge Therapeutics has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Bridge Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-05-24	4	$3,000,000

Funding Insights

$3,000,000

Total funding amount

$3,000,000

Most recent funding amount

Number of funding rounds

Bridge Therapeutics Tech Stack

Discover the technologies and tools that power Bridge Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

Contact Form 7

Form builders

PHP

Programming languages

Open Graph

Miscellaneous

Font Awesome

Font scripts

WordPress

Blogs

IONOS

Hosting

YouTube

Video players

MySQL

Databases

RSS

Miscellaneous

Frequently asked questions

Bridge Therapeutics is located in Birmingham, Alabama, US.

You can reach Bridge Therapeutics at +18772236949.

Bridge Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Bridge Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Bridge Therapeutics has raised a total of $3,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Bridge Therapeutics

Alton Kelley

Director Of Business Development

David H. Bergstrom

Chief Executive Officer

4.8

40,000 users